Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucose Excursion”

Showing 4 of 0 results

Large-scale testing (Phase 3)UnknownNCT02345239
What this trial is testing

Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Dr. Waheed Rehman 14
Post-approval studies (Phase 4)Study completedNCT03659799
What this trial is testing

Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Institut de Recherches Cliniques de Montreal 40
Not applicableLooking for participantsNCT07408479
What this trial is testing

Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance

Who this might be right for
Insulin Resistance
Mondelēz International, Inc. 40
Early research (Phase 1)Study completedNCT02012166
What this trial is testing

MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 18

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation